XML 74 R54.htm IDEA: XBRL DOCUMENT v3.24.0.1
Related Parties Transactions (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Jul. 27, 2021
Jul. 01, 2020
May 08, 2020
Jun. 16, 2022
Jul. 19, 2017
Feb. 24, 2015
Sep. 30, 2023
Sep. 30, 2022
Jun. 30, 2023
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Mar. 31, 2023
Nov. 30, 2022
Dec. 01, 2021
Sep. 30, 2021
Sep. 07, 2021
Jul. 15, 2021
Related Parties Transactions (Details) [Line Items]                                      
Loans bear interest rate       5.00%                              
Additional working capital percentage       6.40%                              
Conversion price, description                   The Company may convert the Note at any time into shares of Rgene’s common stock at either (i) a fixed conversion price equal to $1.00 per share or (ii) 20% discount of the stock price of the then most recent offering, whichever is lower; the conversion price is subject to adjustment as set forth in the Note. The Note includes standard events of default, as well as a cross default provision pursuant to which a breach of the Service Agreement will trigger an event of default under the convertible note if not cured after 5 business days of written notice regarding the breach is provided.                  
Balance of outstanding loans                   $ 500,000   $ 500,000 $ 33,520            
Accrued interest                   32,518   13,819 13,701            
Other receivables             $ 624,373     624,373   757,343              
Loan agreement amount                       507,000              
Outstanding balance amount                   $ 315,947   188,753              
Interest rate             6.50%     6.50%                 2.00%
Accrued interest                       0 $ 0            
Due amount                   $ 107,615   112,822              
Interest expenses             $ 9,327 $ 0   24,400 $ 0                
Outstanding principal and accrued interest             144,460     144,460   151,450              
Interest expenses             5,015 5,208   15,082 15,922                
Discount of stock price                         12.00%            
Related parties transactions, description       the Company entered into a one-year convertible loan agreement with Rgene, with a principal amount of $1,000,000 to Rgene which bears interest at 5% per annum for the use of working capital that, if fully converted, would result in ABVC owning an additional 6.4% of Rgene. The Company may convert the Note at any time into shares of Rgene’s common stock at either (i) a fixed conversion price equal to $1.00 per share or (ii) 20% discount of the stock price of the then most recent offering, whichever is lower; the conversion price is subject to adjustment as set forth in the Note. The Note includes standard events of default, as well as a cross-default provision pursuant to which a breach of the Service Agreement will trigger an event of default under the convertible note if not cured after 5 business days of written notice regarding the breach is provided.                              
Interest rate percentage                             6.50%        
Total loan amount             1,000,000     1,000,000                  
Maturity date         Jul. 18, 2019                            
Aggregated amount     $ 150,000                                
Advanced amount     $ 150,000                                
Outstanding principal and accrued interest                       151,450 $ 168,131            
Interest expenses             $ 1,218,624 $ 126,536   $ 1,390,039 159,507 $ 293,968 227,210            
Minimum [Member]                                      
Related Parties Transactions (Details) [Line Items]                                      
Interest rate                       12.00%              
Ownership percentage                       0.00%              
Maximum [Member]                                      
Related Parties Transactions (Details) [Line Items]                                      
Interest rate                       13.6224%              
Ownership percentage                       1.00%              
Bear Interest Rate [Member]                                      
Related Parties Transactions (Details) [Line Items]                                      
Loan agreement, description                   The advances bear interest rate of 12% per annum.                  
BioFirst (Australia) [Member]                                      
Related Parties Transactions (Details) [Line Items]                                      
Accrued interest                   $ 681,185                  
R&D cost   $ 361,487                                  
Interest rate percentage                               6.50% 6.50%    
Loan agreement amount                               $ 250,000   $ 67,873  
Repaid loan $ 249,975                                    
Research fee                       $ 660,484              
Accrued interest                   141,596   92,171              
Aggregate working capital                       275,901 132,443            
Jiangs [Member]                                      
Related Parties Transactions (Details) [Line Items]                                      
Interest expenses                   $ 499 $ 0                
Jiangs [Member] | Minimum [Member]                                      
Related Parties Transactions (Details) [Line Items]                                      
Loans bear interest rate             0.00%     0.00%                  
Jiangs [Member] | Maximum [Member]                                      
Related Parties Transactions (Details) [Line Items]                                      
Loans bear interest rate             1.00%     1.00%                  
Convertible Debt [Member]                                      
Related Parties Transactions (Details) [Line Items]                                      
Principal amount       $ 1,000,000                              
BioFirst [Member]                                      
Related Parties Transactions (Details) [Line Items]                                      
Maturity date                               Nov. 30, 2022      
Loan agreement, description                   The advances bear interest 1% per month (or equivalent to 12% per annum).                  
Several Loan Agreements [Member] | AUSTRALIA                                      
Related Parties Transactions (Details) [Line Items]                                      
Loan agreement amount                           $ 88,091          
Outstanding balance amount                 $ 25,500                    
Rgene [Member]                                      
Related Parties Transactions (Details) [Line Items]                                      
Due from rgene amounted                       513,819            
Related Party [Member]                                      
Related Parties Transactions (Details) [Line Items]                                      
Other receivables             $ 2,528     $ 2,528   0              
Due amount                         124,972            
Interest expenses                       21,378 22,779            
Related Party [Member] | Rgene [Member]                                      
Related Parties Transactions (Details) [Line Items]                                      
Due from rgene amounted                         49,110            
Due from rgene amounted                         1,889            
BHK Co Development Agreement [Member]                                      
Related Parties Transactions (Details) [Line Items]                                      
Loan agreement, description                   The development costs shall be shared 50/50 between BHK and the Company. Under the term of the agreement, BioLite issued relevant development cost to BHK.                  
Jiangs [Member]                                      
Related Parties Transactions (Details) [Line Items]                                      
Outstanding balance amount                   $ 19,789   19,789              
Outstanding advance                       19,789 $ 18,750            
Rgene [Member]                                      
Related Parties Transactions (Details) [Line Items]                                      
Accrued interest                       13,819              
Other receivables             624,373     624,373   615,118              
Interest rate                         1.00%            
Due from rgene amounted             $ 535,046     $ 535,046   513,819              
BioFirst (Australia) [Member]                                      
Related Parties Transactions (Details) [Line Items]                                      
Accrued interest                       $ 1,028,556 $ 491,816            
Due from rgene amounted   $ 361,487                           $ 250,000      
Interest rate percentage                                 6.50%    
Total loan amount                                   $ 67,873  
Maturity date                       Nov. 30, 2022              
Ownership percentage                       6.50%              
BHK Co Development Agreement [Member]                                      
Related Parties Transactions (Details) [Line Items]                                      
Loan agreement, description           The development costs shall be shared 50/50 between BHK and the Company. Under the term of the agreement, BioLite issued relevant development cost to BHK.                          
BioLite Japan [Member]                                      
Related Parties Transactions (Details) [Line Items]                                      
Interest rate percentage     0.00%                                
Outstanding advance                       $ 0 150,000            
BioFirst [Member]                                      
Related Parties Transactions (Details) [Line Items]                                      
Balance of outstanding loans                       188,753 147,875            
Accrued interest                       $ 40,878 $ 40,878            
Interest rate                       1.00%              
Discount of stock price                       12.00%